一家專業生產植絨拭子的製造商 & CHG產品.
China’s COVID-19 Oral Pill Gets Regulatory Approval
2022-07-27
China’s top drug regulator said on Monday it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19.
Azvudine, developed by Genuine Biotech Co Ltd based in Henan province, was first approved to treat HIV/AIDS patients on July 20 last year, according to the National Medical Products Administration.
The approval clears the way for the pill to be used for adults with moderate COVID-19 symptoms, the administration said in a notice released on its official website.
中國日報
也許你也喜歡
版權所有©2023. 醫療技術公司, 有限公司
